MedPath
NMPA Approval

Ranitidine Hydrochloride Capsules

国药准字H63020138

March 20, 2020

Drug Information

盐酸雷尼替丁胶囊

胶囊剂

0.15g(以C13H22N4O3S计)

化学药品

March 20, 2020

Company Information

Applicant Company

Manufacturing Company

青海生物科技产业园经四路20号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.